Source document or public record

FDA 510(k) K232624 — CardioPhase® hsCRP

FDA 510(k) index record K232624. Device: CardioPhase® hsCRP. Applicant as listed: Siemens Healthcare Diagnostic Products GmbH. Decision date: 2023-11-27.

OtherU.S. Food and Drug Administration (FDA)2023-11-27

Source

"device_name": "CardioPhase® hsCRP"

This entry describes what the document covers; the document itself is the authority. Listing it is not agreement with its conclusions.

Review and references

Reviewer

Automated FDA record verification

Published

2026-10-20

Updated

2026-10-20

Disclaimer

professional use

FDA 510(k) public index record K232624.

Device name: CardioPhase® hsCRP. Applicant as listed: Siemens Healthcare Diagnostic Products GmbH.

Decision date: 2023-11-27. Decision wording: Substantially Equivalent.

Product code: DCN. Regulation: 21 CFR 866.5270. Medical specialty: Immunology.

This page reproduces regulator index metadata. The applicant field identifies the submitter and is not a manufacturer identity check. Consult the original FDA record for the decision and associated documents; this index does not verify current commercial availability or clinical performance.

Interested in these solutions?

Submit a sourcing request with the assays, volumes, and timeline of your own project.